Compare ARK Genomic Revolution ETF (ARKG) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Victoria's Secret & Co — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Victoria's Secret & Co trades at $78.36 (market cap $6.23B). Which is the better fit depends on your goals.
| ARKG | VSXY | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $88.50 |
52-Week Low | $23.09 | $17.70 |
Market Cap | — | $6.23B |
Enterprise Value | — | $8.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Victoria's Secret (VSXY) trades at $78.36, up 2.85% today, showing strong momentum with consistent earnings beats in recent quarters. The stock exhibits bullish technical signals with support at $75 and resistance at $78. Fundamentally, the company maintains solid revenue around $6.2B with improving net margins, while international growth in China and Europe drives optimism. Analyst consensus is bullish with a $88.56 price target, supported by 55.6% buy ratings.
Outlook remains positive with international expansion and margin recovery as key catalysts, though risks include competitive pressures and execution challenges. The stock offers potential upside to analyst targets but requires monitoring of consumer spending trends and debt levels. Current valuation at P/E 31.22 appears reasonable given growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
